|
× |
 |
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort PDF |
$40.00 |
|
$40.00 |
|
× |
|
Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium PDF |
$40.00 |
|
$40.00 |
|
× |
|
Secondary Trigeminal Neuralgia Due to Multiple Sclerosis in a Patient With Opioid Use Disorder Treated With Buprenorphine/Naloxone PDF |
$40.00 |
|
$40.00 |
|
× |
|
Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions PDF |
$40.00 |
|
$40.00 |
|
|